Lakshmi A Devi

pharmacological sciences Icahn School of Medicine at Mount Sinai, New York, NY, United States 
"Lakshmi Devi"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lemos Duarte M, Trimbake NA, Gupta A, et al. (2021) High-throughput screening and validation of antibodies against synaptic proteins to explore opioid signaling dynamics. Communications Biology. 4: 238
Gupta A, Gullapalli S, Pan H, et al. (2021) Regulation of Opioid Receptors by Their Endogenous Opioid Peptides. Cellular and Molecular Neurobiology
Fricker LD, Tashima AK, Fakira AK, et al. (2020) Neuropeptidomic Analysis of a Genetically Defined Cell Type in Mouse Brain and Pituitary. Cell Chemical Biology
Fakira AK, Devi LA, Kennedy PJ. (2020) Novel Application for G Protein-Biased Mu Opioid Receptor Agonists in Opioid Relapse Prevention. Biological Psychiatry. 88: 896-897
Faouzi A, Uprety R, Gomes I, et al. (2020) Synthesis and Pharmacology of a Novel μ-δ Opioid Receptor Heteromer-Selective Agonist Based on the Carfentanyl Template. Journal of Medicinal Chemistry
Palma JA, Gupta A, Sierra S, et al. (2020) Autoantibodies blocking M muscarinic receptors cause postganglionic cholinergic dysautonomia. Annals of Neurology
Fricker LD, Margolis E, Gomes I, et al. (2020) Five decades of research on opioid peptides: Current knowledge and unanswered questions. Molecular Pharmacology
Gomes I, Sierra S, Lueptow L, et al. (2020) Biased signaling by endogenous opioid peptides. Proceedings of the National Academy of Sciences of the United States of America
Sierra S, Gupta A, Gomes I, et al. (2019) Targeting Cannabinoid 1 and Delta Opioid Receptor Heteromers Alleviates Chemotherapy-Induced Neuropathic Pain. Acs Pharmacology & Translational Science. 2: 219-229
McDermott MV, Afrose L, Gomes I, et al. (2019) Opioid-induced signaling and antinociception are modulated by the recently deorphanized receptor, GPR171. The Journal of Pharmacology and Experimental Therapeutics
See more...